J Immunol:过敏性鼻炎患者鼻过敏原挑战外周血免疫基因特性调查

2017-10-24 AlexYang MedSci原创

鼻过敏原挑战(NAC)是过敏性鼻炎(AR)的一种人类模型,具体是通过局部地接种标准的过敏原到鼻粘膜上,从而引起临床症状以及生物样本的搜集,比如外周血的搜集。尽管许多研究集中在了局部炎症位点,一个重要的调控子和系统免疫响应的成员-外周血在AR中却并没有很好的研究。最近,有研究人员调查了在患有AR的病人经历NAC之后,外周血中免疫基因的特性。研究人员在NAC处理期间搜集了临床症状信息和外周血样本,并利

鼻过敏原挑战(NAC)是过敏性鼻炎(AR)的一种人类模型,具体是通过局部地接种标准的过敏原到鼻粘膜上,从而引起临床症状以及生物样本的搜集,比如外周血的搜集。尽管许多研究集中在了局部炎症位点,一个重要的调控子和系统免疫响应的成员-外周血在AR中却并没有很好的研究。

最近,有研究人员调查了在患有AR的病人经历NAC之后,外周血中免疫基因的特性。研究人员在NAC处理期间搜集了临床症状信息和外周血样本,并利用模糊c均值聚类方法鉴定了免疫基因在不同时间点(在NAC之前1和2小时以及NAC后6小时)的表达模式。研究人员鉴定和确定了NAC处理后的7种差异化表达的免疫基因聚类。在抗原挑战后,聚类2、3和4与嗜中性粒细胞、淋巴细胞频率和嗜中性粒细胞/淋巴细胞比例相关。聚类的模式和免疫细胞频率与AR患者的临床症状相关,并且与健康非过敏且经历NAC的参试者具有显著的差异。

最后,研究人员指出,他们的方法鉴定了免疫基因在血液中的表达可作为一种系统免疫响应与NAC后的临床症状相关这一动态特性。免疫基因特性也许允许人们对AR病理生理进行具有代表性的调查,并且结合NAC模型,也许是AR诊断和治疗的有用的潜在方法。

原始出处:


本文系williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2060912, encodeId=402d206091299, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Fri Dec 29 13:03:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046893, encodeId=9289204689348, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jul 19 15:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660336, encodeId=22f816603363f, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Fri Oct 05 22:03:00 CST 2018, time=2018-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442614, encodeId=a3cc14426148e, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578530, encodeId=986415e85307d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255807, encodeId=19b225580e7a, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Oct 25 08:12:53 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2060912, encodeId=402d206091299, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Fri Dec 29 13:03:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046893, encodeId=9289204689348, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jul 19 15:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660336, encodeId=22f816603363f, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Fri Oct 05 22:03:00 CST 2018, time=2018-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442614, encodeId=a3cc14426148e, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578530, encodeId=986415e85307d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255807, encodeId=19b225580e7a, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Oct 25 08:12:53 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2060912, encodeId=402d206091299, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Fri Dec 29 13:03:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046893, encodeId=9289204689348, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jul 19 15:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660336, encodeId=22f816603363f, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Fri Oct 05 22:03:00 CST 2018, time=2018-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442614, encodeId=a3cc14426148e, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578530, encodeId=986415e85307d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255807, encodeId=19b225580e7a, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Oct 25 08:12:53 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2060912, encodeId=402d206091299, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Fri Dec 29 13:03:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046893, encodeId=9289204689348, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jul 19 15:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660336, encodeId=22f816603363f, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Fri Oct 05 22:03:00 CST 2018, time=2018-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442614, encodeId=a3cc14426148e, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578530, encodeId=986415e85307d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255807, encodeId=19b225580e7a, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Oct 25 08:12:53 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2060912, encodeId=402d206091299, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Fri Dec 29 13:03:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046893, encodeId=9289204689348, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jul 19 15:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660336, encodeId=22f816603363f, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Fri Oct 05 22:03:00 CST 2018, time=2018-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442614, encodeId=a3cc14426148e, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578530, encodeId=986415e85307d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255807, encodeId=19b225580e7a, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Oct 25 08:12:53 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2060912, encodeId=402d206091299, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Fri Dec 29 13:03:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046893, encodeId=9289204689348, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Jul 19 15:03:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660336, encodeId=22f816603363f, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Fri Oct 05 22:03:00 CST 2018, time=2018-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442614, encodeId=a3cc14426148e, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578530, encodeId=986415e85307d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Thu Oct 26 13:03:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255807, encodeId=19b225580e7a, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Oct 25 08:12:53 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
    2017-10-25 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

相关威廉亚洲官网

秋季哮喘高发,上下气道共治

一阵秋雨一阵凉,由于秋季空气逐渐变冷、昼夜温差大,再伴随过敏原、呼吸道病毒开始活跃等问题,哮喘的发病率明显增多。也许很多人没有注意到,过敏性鼻炎和哮喘很多时候存在“共生”关系,哮喘会合并过敏性鼻炎,而反复的严重过敏性鼻炎发作以后,病人慢慢会出现咳嗽和气喘。专家指出,哮喘和过敏性鼻炎是“同一气道,同一疾病”,有鼻炎的哮喘病人,两个病要联合治疗。而对于家长关心的激素长期使用是否会上瘾,什么时候才能

Rhinology:P-AzeFlu可以快速和有效的控制过敏性鼻炎

过敏性鼻炎和它对哮喘的影响(ARIA)以及欧盟(EU)推荐了指导过敏性鼻炎(AR)治疗选定的改变,即从症状反应到疾病控制,并使用了一个简单的视觉模拟评分体系(VAS)。最近,有研究人员利用VAS评估了MP-AzeFlu鼻用喷雾在罗马尼亚现实研究中的效果。在该多中心,前瞻性和非干预性研究中,253名(大于11岁)患有中等程度到重度AR的病人进行了MP-AzeFlu治疗,并且研究人员利用VAS(从0-

Mediators Inflamm:IL-25参与了屋尘螨敏感的过敏性鼻炎的发展

屋尘螨是一种常见的过敏,当屋尘螨(HDM)附着到黏膜上的时候,它可以刺激先天免疫。然而,IL-25在HDM诱导的鼻过敏性炎症中的精确角色仍旧不清楚。因此,最近有研究人员调查了屋尘螨敏感的过敏性鼻炎(AR)中的IL-25的作用。为了确认IL-25在人类鼻上皮细胞(HNECs)的产生,研究人员刺激了HNECs,并利用免疫组化技术和定量反转录PCR技术评估了IL-25在对照组、非AR病人(NAR)和HD

Clin Immunol:过敏性鼻炎患者对屋尘螨增加的先天2型免疫响应

2型先天淋巴样细胞(ILC2s)在起始和促进过敏免疫响应中是必要的成员。然而,研究人员在探究过程中发现了ILC2水平的过敏性鼻炎(AR)患者中的不一致性。最近,有研究人员调查了ILC2在屋尘螨(HDM)过敏性AR病人外周血中的水平,并且还调查了他们分泌2型细胞激素的能力。研究发现,ILC2s且具有ILC2表型特性的水平在HDM-AR病人中增加。AR病人的症状得分和IL-13的水平与HDM-AR病人

Rhinology:过敏性鼻炎和非过敏性鼻炎病人鼻甲成形术后气流和症状结果分析

下鼻甲成形术被用来减轻医疗上难治性鼻阻塞。然而,阻塞的本质原因在过敏性鼻炎(AR)和非过敏性鼻炎(NAR)病人中是不同的。最近,有研究人员比较了术后AR病人和NAR病人治疗结果。研究人员设计的研究为案例-对照研究。参与的病人因鼻阻塞经历了鼻甲手术,其中包括具有鼻中隔成形术手术和不具有鼻中隔成形术手术。病人报道的结果有:鼻阻塞情况、全鼻功能(GNF)和鼻炎的鼻腔鼻窦结局测试(SNOT-22)、面部症

Health Qual Life Outcomes:屋尘螨和花粉过敏性鼻炎病人舌下免疫治疗生活品质的改善研究

过敏性鼻炎具有较高的流行度,并且它的负担对病人的日常生活品质造成了严重的影响。过敏性鼻炎与日常活动、工作、学习以及现实问题的干扰有关。并且,病人还要承受睡眠障碍和情绪问题。舌下免疫治疗在生活品质方面的优势最近才得以重视。最近,有研究人员进行了前瞻性的现实生活研究,旨在评估为期3年的舌下免疫治疗对屋尘螨(HDM)花粉提取物过敏成年人的生活品质的影响。研究包括了191名成年人(105名男性;平均年龄为